You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
BMS 599626 dihydrochloride
Biological Activity for BMS 599626 dihydrochloride
BMS 599626 dihydrochloride is a potent and selective EGFR and ErbB2 inhibitor (IC50 values are 22 nM and 32 nM respectively). Also inhibits HER4 (IC50 = 190 nM). Inhibits EGFR and ErbB2 with 100-fold greater potency than MEK and Lck. Antiproliferative agent in vitro and anti-tumorigenic agent in vivo. Orally bioavailable.
Compound Libraries for BMS 599626 dihydrochloride
Technical Data for BMS 599626 dihydrochloride
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for BMS 599626 dihydrochloride
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|water||3.02||5 with gentle warming|
Preparing Stock Solutions for BMS 599626 dihydrochloride
The following data is based on the product molecular weight 603.48. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.66 mL||8.29 mL||16.57 mL|
|5 mM||0.33 mL||1.66 mL||3.31 mL|
|10 mM||0.17 mL||0.83 mL||1.66 mL|
|50 mM||0.03 mL||0.17 mL||0.33 mL|
Product Datasheets for BMS 599626 dihydrochloride
References for BMS 599626 dihydrochloride
References are publications that support the biological activity of the product.
Wong et al (2006) Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling. Clin.Cancer Res. 12 6186 PMID: 17062696
Gavai et al (2009) Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficaciou J.Med.Chem. 52 6527 PMID: 19821562
If you know of a relevant reference for BMS 599626 dihydrochloride, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: BMS 599626 dihydrochloride, BMS 599626 dihydrochloride supplier, BMS599626, potent, selective, HER1, HER2, EGFR, erbB-2, erbB2, tyrosine, kinase, inhibitors, inhibits, kinases, receptors, growth, factor, Neu, antitumor, antitumour, antiproliferative, 5022, Tocris Bioscience
Citations for BMS 599626 dihydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for BMS 599626 dihydrochloride. Do you know of a great paper that uses BMS 599626 dihydrochloride from Tocris? Please let us know.
Reviews for BMS 599626 dihydrochloride
There are currently no reviews for this product. Be the first to review BMS 599626 dihydrochloride and earn rewards!
Have you used BMS 599626 dihydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.